Oxford University Hospitals

The trials here

What the 12 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Aortic aneurysm1 trial
• Childhood cancers1 trial
• Coronary artery disease1 trial
• Duchenne muscular dystrophy1 trial
• Gastric and oesophageal cancer1 trial
• Heart failure1 trial
• HIV1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Myeloproliferative neoplasms1 trial
• Parkinson disease1 trial
• and 1 more

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Recruiting5 trials
• Active, not recruiting3 trials
• Completed2 trials
• Not yet recruiting2 trials

Lead sponsor

• Imperial College London2 trials
• Amsterdam UMC1 trial
• Amsterdam UMC, location VUmc1 trial
• AO Innovation Translation Center1 trial
• CoreAalst BV1 trial
• and 6 more

Running trials

• Not yet recruiting

  The U.K. NorthStar Clinical Network

  NCT06711692· University College, London· Source

  Contact: Richard Tarver

• Recruiting

  Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer

  NCT05180864· Amsterdam UMC· Source

  Contact: Suzanne S. Gisbertz, MD, PhD

• Recruiting

  Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression

  NCT06206369· Amsterdam UMC, location VUmc· Source

  Contact: Regent Lee

• Recruiting

  Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades

  NCT06052475· Imperial College London· Source

  Contact: Julian Ormerod

• Active, not recruiting

  Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression

  NCT04920708· Phase 2· Royal Marsden NHS Foundation Trust· Source

• Active, not recruiting

  The Euro-CRAFT Registry

  NCT05805462· CoreAalst BV· Source

• Recruiting

  Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

  NCT05429632· Phase 3· Priothera SAS· Source

  Contact: Kirsty Sharplin, MD

• Recruiting

  A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

  NCT04319367· Phase 2· Imperial College London· Source

  Contact: Paola Cicconi

• Active, not recruiting

  A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

  NCT04576156· Phase 3· Geron Corporation· Source

• Recruiting

  Primary Tumor Research and Outcomes Network

  NCT02790983· AO Innovation Translation Center· Source

  Contact: Jeremy Reynolds

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting
• Aortic aneurysm1 recruiting
• Childhood cancers1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Heart failure1 recruiting
• HIV1 recruiting
• Peripheral artery disease1 recruiting

Closed trials

• Completed

  Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients

  NCT05888584· Oxford Brookes University· Source

• Completed

  CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)

  NCT04226248· Phase 3· University of Bristol· Source